1.Biocompatibility of macrophages with quantum dots
Chong LI ; Cheng YAN ; Huimin JIN ; Shuiyun WU ; Yetao QIANG ; Nannan YAN ; Tengfei XIAO ; Sheng XIA
Chinese Journal of Tissue Engineering Research 2017;21(26):4217-4221
BACKGROUND: Compared with the traditional organic fluorescent dyes, quantum dots present good biomarker characteristics. Especially, quantum dots for cell labeling and targeted bioimaging present unique optical properties.OBJECTIVE: To investigate the biocompatibility of CdSe/ZnS quantum dots with mononuclear macrophages.METHODS: The macrophages RAW264.7 were inoculated into 96-well plates containing 0, 50, 100 mg/L CdSe/ZnS quantum dots for 1 or 2 hours. Then, the fluorescent signal was detected by flow cytometry. After 0-24 hours of culture,the fluorescence signal intensity of the macrophages cultured with 50 mg/L CdSe/ZnS quantum dots was detected by flow cytometry. After 18 hours of culture, quantitative PCR was used to detect the levels of tumor necrosis factor α and interleukin 1β in macrophages, and macrophage proliferation cell apoptosis were detected by MTT and flow cytometry,respectively.RESULTS AND CONCLUSION: The fluorescence signal intensity was positively correlated with the mass concentration of CdSe/ZnS quantum dots, and the intensity of the fluorescent signal was increased with the labeling time. After labeling using 50 mg/L CdSe/ZnS quantum dots, the fluorescence signal of macrophages increased continuously with time, and reached the peak at 18 hours. Compared with 0 mg/L quantum dot group, 50, 100mg/L quantum dot groups could significantly promote the expression of tumor necrosis factor α and interleukin 1β in macrophages (P < 0.01 or P < 0.05).The level of tumor necrosis factor α in the 100 mg/L quantum dot group was higher than that in the 50 mg/L quantum dot group (P < 0.01). The expression of interleukin-1β showed no difference between 50 and 100 mg/L quantum dot groups.The cell proliferation in the 50 and 100 mg/L CdSe/ZnS quantum dot groups was significantly higher than that in the 0 mg/L quantum dot group (P < 0.05), but there was no difference between the former two groups. In addition, 50 and 100 mg/L CdSe/ZnS quantum dots had no significant effect on apoptosis of macrophages. To conclude, CdSe/ZnS quantum dots could activate macrophages and promote their proliferation and secretion of inflammatory factors, but did not affect their apoptosis.
2.Effect of laparoscopic uterine artery occlusion combined with myomectomy on treatment of patients with uterine fibroids
Shuiyun LI ; Yongmei ZENG ; Ping WU
Journal of Clinical Medicine in Practice 2014;(15):88-91
Objective To explore the clinical effect of laparoscopic uterine artery occlusion combined with myomectomy on treatment of patients with uterine fibroids.Methods 112 patients with uterine fibroids were randomly divided into the observation group (n=56)and the control group (n=56),the observation group was treated with laparoscopic uterine artery occlusion com-bined with myomectomy,while the control group was treated with laparoscopic myomectomy only. Clinical effect was contrasted between the two groups.Results In the observation group,operative time and hospital stay were significantly shorter than the control group(P <0.01),blood loss was less than the control group(P <0.01),and the exhaust time was significantly earlier than the con-trol group(P <0.05).In the observation group,remission rate of menorrhagia was 96.4%,which was significantly higher than 80.4% in the control group(P <0.01).Uterine fibroid recurrence rate was 1.8%,which was significantly lower than 16.1% in the control group(P <0.01),but degree of uterine volume reduction was significantly higher than the control group(P <0.01). There was no significant difference of incidence of postoperative complications between the two groups.Conclusion Laparoscopic uterine artery occlusion combined with myomectomy can effec-tively reduce intraoperative loss of blood,improve therapeutic efficacy and reduce incidence rate of complications and recurrence rate.
3.Effect of laparoscopic uterine artery occlusion combined with myomectomy on treatment of patients with uterine fibroids
Shuiyun LI ; Yongmei ZENG ; Ping WU
Journal of Clinical Medicine in Practice 2014;(15):88-91
Objective To explore the clinical effect of laparoscopic uterine artery occlusion combined with myomectomy on treatment of patients with uterine fibroids.Methods 112 patients with uterine fibroids were randomly divided into the observation group (n=56)and the control group (n=56),the observation group was treated with laparoscopic uterine artery occlusion com-bined with myomectomy,while the control group was treated with laparoscopic myomectomy only. Clinical effect was contrasted between the two groups.Results In the observation group,operative time and hospital stay were significantly shorter than the control group(P <0.01),blood loss was less than the control group(P <0.01),and the exhaust time was significantly earlier than the con-trol group(P <0.05).In the observation group,remission rate of menorrhagia was 96.4%,which was significantly higher than 80.4% in the control group(P <0.01).Uterine fibroid recurrence rate was 1.8%,which was significantly lower than 16.1% in the control group(P <0.01),but degree of uterine volume reduction was significantly higher than the control group(P <0.01). There was no significant difference of incidence of postoperative complications between the two groups.Conclusion Laparoscopic uterine artery occlusion combined with myomectomy can effec-tively reduce intraoperative loss of blood,improve therapeutic efficacy and reduce incidence rate of complications and recurrence rate.
4.Immunomodulatory effects of butyrate on bone marrow derived dendritic cells
Yetao QIANG ; Shuiyun WU ; Mutian HAN ; Lu CHENG ; Huimin JIN ; Cheng YAN ; Chong LI ; Xia LIU ; Miaomiao ZHANG ; Qixiang SHAO ; Sheng XIA
Chinese Journal of Immunology 2015;(10):1315-1319
Objective:To investigate the effect of butyrate produced by bacterial metabolism on immune features of murine bone marrow-derived dendritic cells(BMDCs) and its potential mechanisms.Methods: BMDCs were prepared from bone marrow cells of C57BL/6 mice by being cultured with GM-CSF and IL-4.The expression of CD80,CD86,B7-DC and MHCⅡ on BMDCs and its pri-ming ability on the proliferation of OVA257-264 antigen specific CD8+T cell were analyzed by using Flow cytometry.The mRNA levels of IL-6 and IL-12 in BMDCs were detected by real-time fluorescence quantitative PCR(q-PCR).Simultaneously,Griess reaction and Western blot was used for analyzing the levels of NO2-in BMDCs culture supernatant and the ERK phosphortylation in BMDCs respectivly.Results:Butyrate could decrease the levels of CD80,CD86,MHCⅡand B7-DC,and downregulate the capability of BMDCs in priming the proliferation of CD8+T cells.Furthermore,the secretions of IL-6,IL-12,NO2-and the phosphorylation of ERK were sup-pressed.Conclusion:Butyrate down-regulats the immune functions of BMDCs via inhibition of ERK phosphorylation in TLR 4 signaling pathway.
5.Mid-term Outcomes of Surgical Effect in Patients With Hypertrophic Obstructive Cardiomyopathy Combining Mid Left Ventricular Obstruction
Yajie TANG ; Yunhu SONG ; Shuiyun WANG ; Wei WANG ; Jianping XU ; Hansong SUN ; Xin WANG ; Sheng LIU ; Ge GAO ; Jun RAN ; Haojie LI ; Yun LIU ; Fujian DUAN
Chinese Circulation Journal 2016;31(6):578-582
Objective: To summarize the mid-term effect of modified extended Morrow procedure in patients with hypertrophic obstructive cardiomyopathy (HOCM) combining sub aortic valve obstruction and mid left ventricular obstruction. Methods: We studied 34 consecutive HOCM patients with sub aortic and midventricular obstruction who received modiifed extended Morrow procedure with extracorporeal circulation in our hospital from 1996-11 to 2015-01. Transthoracic echocardiography was conducted at pre-, post-operation and follow-up period to evaluate the changes of mid-ventricular gradient, subarctic gradient and each heart valve function. Results: The average follow-up time was (25.7 ± 14.9) months, 2 patients lost contact and no death occurred. In rest 32 patients, the mid ventricular gradient decreased from (60.3 ± 29.4) mmHg to (21.0 ± 19.8) mmHg, subaortic valve gradient decreased from (77.9 ± 26.2) mmHg to (11.6 ± 6.5) mmHg, the maximum ventricular septal thickness dropped from (25.2 ± 4.9) mm to (17.9 ± 7.2) mm, left atrial diameter reduced from (41.1 ± 7.8) mm to (37.6 ± 6.4) mm, left ventricular end-diastolic diameter increased from (39.8 ± 5.1) mm to (42.2 ± 4.3) mm, allP<0.05; there were 5 patients without obviously improved mid ventricular gradient because of insufifcient resection of septal myocardium in mid-ventricle. The post-operative NYHA classiifcation was improved,P<0.01, mitral valve regurgitation degree was decreased,P<0.01 and SAM phenomenon was disappeared. Complications included 3 (8.8%) patients of III atrio-ventricular block, 1 (2.9%) patient of re-admission due to poorly healed sternum combining pneumonia Conclusion: Modified extended Morrow procedure may relieve sub aortic valve and mid ventricular obstruction, therefore improve left ventricular diastolic function and prognosis in relevant patients.
6.Medium-long Term Outcomes of Ventricular Septal Myectomy for Treating the Patients With Hypertrophic Obstructive Cardiomyopathy-A Single Center Experience
Haojie LI ; Yunhu SONG ; Xiaodong ZHU ; Shengshou HU ; Zhe ZHENG ; Shuiyun WANG ; Hansong SUN ; Wei WANG ; Jianping XU ; Hui XIONG ; Xin WANG ; Jun YAN ; Xiaoqi WANG ; Yun LIU ; Jun RAN ; Yajie TANG
Chinese Circulation Journal 2016;31(6):573-577
Objective: To report the medium-long term survival rates of ventricular septal myectomy for treating the patients with hypertrophic obstructive cardiomyopathy and to analyze the predictive factors affecting the outcomes. Methods: A total of 655 consecutive patients who received ventricular septal myectomy in our hospital from 1984-10 to 2014-12 were retrospectively summarized. The cohort study was conducted with questionnaires by cardiovascular nurses. Result: The operative mortality was 1.4% (9/655). The mean follow-up time was (30.8 ± 30.9, from 3 to 213) months, there were 52/646 (7.9%) patients lost contact and 583 patients having NYHA classification at I or II during that period. The overall survival rates for 1 year, 5-year and 8-year were 98.3%, 90.5% and 88.3% respectively. There were 80 patients suffered from end point events including HCM-related death, heart transplantation, repeated myectomy, permanent pacemaker implantation and re-admission for ischemic stroke, tachyarrhythmia, myocardial ischemia or infarction, congestive heart failure. The end point events free survival rates for 1 year, 5-year and 8-year were 94.2%, 76.7% and 65.9% respectively. Multivariable Cox regression analysis presented that age>50 years (HR=2.16, 95% CI 1.36-3.46,P=0.001) and pre-operative atrial ifbrillation (FA) (HR=2.31, 95% CI 1.35-3.94,P=0.002) were the independent predictors for end point events occurrence. Conclusion: Ventricular septal myectomy may achieve good medium-long term survival rate with less adverse event in patients with hypertrophic obstructive cardiomyopathy. Elder than 50 years of age and with pre-operative FA were the independent predictors for adverse events occurrence.
7.Review of the infectious intracranial aneurysms secondary to the infective endocarditis
Chinese Journal of Thoracic and Cardiovascular Surgery 2023;39(8):509-512
Patients diagnosed as infective endocarditis(IE) are prone to follow with a variety of brain lesions, among which infective intracranial aneurysm(IIA) is a very rare cerebrovascular disease, could also be found in IE patients. IIA always has a great influence on patients’ prognoses. The incidence of this kind of aneurysm varies in different investigations, and was reported in mostly about 10% of cerebrovascular complications. The most popular pathogens causing IIA are streptococci and staphylococci, which are similar to the common pathogens of IE. IIA is a kind of pseudoaneurysm with various pathological changes and pathogenesis. The diameter of aneurysm would increases gradually with the time passing, and finally ends with intracranial hemorrhage or subarachnoid hemorrhage. The examination methods mainly include cerebral-enhanced CT and cerebral contrast-enhanced magnetic resonance imaging, but cerebral angiography is still the gold standard. There are drug therapy, surgery, interventional therapy, and other treatment methods. At present, interventional therapy is the first choice in clinical practice. Surgery is recommended if intervention is unavailable. In terms of the relationship between the operation of IE and IIA treatment, there is still a lack of evidence to give priority to cardiac surgery or IIA. Therefore, it should be considered individually according to the patient’s specific situation.
8.Myocardial remodeling assessed by MR feature tracking in hypertrophic obstructive cardiomyopathy after surgical myectomy
Shujuan YANG ; Keshan JI ; Shiqin YU ; Weipeng YAN ; Rui LI ; Kai YANG ; Shengwei WANG ; Shuiyun WANG ; Shihua ZHAO
Chinese Journal of Radiology 2021;55(8):835-840
Objective:To investigate the changes of strains based on feature tracking in patients with hypertrophic obstructive cardiomyopathy (HOCM) after surgical myectomy and the potential factors that influenced post-myectomy global strains.Methods:A total of 27 patients with HOCM who underwent septal myectomy in Fuwai Hospital from June 2014 to July 2017 were retrospectively collected. They all received cardiac MR (CMR) cine acquisitions before and after surgery. Their preoperative and postoperative strain parameters, including radial strain (RS), circumferential strain (CS), and longitudinal strain (LS) of the global left ventricle, septum, and lateral wall, were assessed by feature tracking. Comparisons of pre-myectomy and post-myectomy imaging parameters were performed using paired-samples t-test or Wilcoxon matched-pairs signed-ranks test. Pearson or Spearman correlation analysis and linear regression analysis were utilized to find the correlated factors of postoperative global strains. Results:Compared with preoperative strains, postoperative global LS, septal LS, lateral RS, lateral CS, and lateral LS increased statistically (all P<0.05); postoperative global RS, global CS, and septal CS decreased (all P<0.05); no statistically significant difference was observed in septal RS ( P=0.165). Age at surgery ( r=0.428, P=0.026) and preoperative myocardial maximum ventricular wall thickness ( r=-0.587, P=0.001) were both linearly related to postoperative global RS; the further multivariate stepwise linear regressions showed that only preoperative myocardial maximum ventricular wall thickness might be correlated with postoperative global RS (adjusted R 2=0.287, P=0.002). Only myocardial maximum ventricular wall thickness was linearly related to global CS ( r=0.679, P<0.001) and global LS ( r=0.588, P=0.001), respectively; univariate linear regression revealed that preoperative myocardial maximum ventricular wall thickness might be correlated postoperative global CS (adjusted R 2=0.337, P=0.001) and postoperative global LS (adjusted R 2=0.281, P=0.003), respectively. Conclusions:Cardiac surgery definitely relieves left ventricular outflow tract obstruction and generally improves longitudinal and lateral strains, but a negative impact may occur in global and septal CS and RS. Preoperative maximum ventricular wall thickness may affect postoperative global strains.
9.Interpretation of perioperative care in cardiac surgery: A joint consensus statement by the Enhanced Recovery after Surgery (ERAS) Cardiac Society, ERAS International Society, and the Society of Thoracic Surgeons (STS)
Yanhai MENG ; Shuo CHANG ; Jigao SHANG ; Zemeng LI ; Yanbo ZHANG ; Shuiyun WANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(12):1728-1734
Enhanced recovery after surgery (ERAS) has been proven to reduce surgical injuries, promote recovery, and improve postoperative outcomes in different types of surgeries. A core principle of ERAS is to provide programmatic evidence-based perioperative interventions. An international multidisciplinary expert group provided a statement on clinical practice in each thematic area of ERAS by obtaining a list of potential ERAS elements, and reviewing literature. The version 2024 of "Perioperative care in cardiac surgery: A joint consensus statement by the Enhanced Recovery After Surgery (ERAS) Cardiac Society, ERAS International Society, and the Society of Thoracic Surgeons (STS)" is developed from the version 2019 of "Guidelines for perioperative care in cardiac surgery: Enhanced Recovery after Surgery Society recommendations". The consensus statement group was composed of multidisciplinary experts such as cardiac surgeons, anesthesiologists, intensive care physicians, and nurses, based on personal ERAS knowledge and experience. This article interprets the changes and new statements in the 2024 consensus, which can provide a foundation for the best perioperative practices for adult cardiac surgery patients.
10.Risk factors and predictive value of estimated glomerular filtration rate for new-onset atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy after modified extended Morrow procedure
Yanhai MENG ; Ping LIU ; Yanbo ZHANG ; Shengwei WANG ; Changsheng ZHU ; Shuo CHANG ; Qi QI ; Enci HU ; Liang LI ; Zina LIU ; Shuiyun WANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2021;28(10):1234-1241
Objective To explore the association between preoperative, perioperative parameters, especially estimated glomerular filtration rate (eGFR) and postoperative atrial fibrillation (POAF) after modified extended Morrow procedure. Methods A total of 300 hypertrophic obstructive cardiomyopathy (HOCM) patients who underwent modified extended Morrow procedure in our hospital from January 2012 to March 2018 were collected. There were 197 (65.67%) males and 103 (34.33%) females with an average age of 43.54±13.81 years. Heart rhythm was continuously monitored during hospitalization. The patients were divided into a POAF group (n=68) and a non-POAF group (n=232). The general data, perioperative parameters and echocardiographic results were collected by consulting medical records for statistical analysis. Univariate and multivariate logistic regression models were used to analyze the risk factors for POAF. Results Overall incidence of POAF during hospitalization was 22.67% (68/300). Compared with patients without POAF, patients with POAF were older, had higher incidence of chest pain and syncope, lower level of preoperative eGFR, higher body mass index and heart function classification (NYHA), larger preoperative left atrial diameter and left ventricular end diastolic diameter, and longer ventilator-assisted time, ICU stay and postoperative hospital stay. Age, heart function classification (NYHA)≥Ⅲ, hypertension, syncope history and eGFR were independent risk factors for POAF. Receiver operating characteristic curve analysis showed that the area under the curve of eGFR was 0.731 (95%CI 0.677-0.780, P<0.001), and the sensitivity and specificity were 82.4% and 57.8%, respectively. Conclusion Increased age, high preoperative heart function classification (NYHA), hypertension, preoperative syncope history and decreased eGFR are independent risk factors for POAF in HOCM patients who underwent surgical septal myectomy. Preoperative decreased eGFR can moderately predict the occurrence of POAF after modified extended Morrow procedure.